Results
26,449 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Wu LeiDirector, Chief Executive Officer, 10% Owner |  GCTGigaCloud Technology IncOpen-market sale · 10b5-1 plan | SELL | $448K 10.8K sh | Mar 20, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $448K 10.8K sh | Mar 20, 2026 |
| 12 | Herraiz Lizette BenediGENERAL COUNSEL |  STRAStrategic Education, Inc.Open-market sale · 10b5-1 plan | SELL | $238K 2,982 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 11 | Dieter DavidEVP & General Counsel |  COLLCOLLEGIUM PHARMACEUTICAL, INCOpen-market sale · 10b5-1 plan | SELL | $488K 14.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Keough KelliEVP, GBUL, SIPS |  SOFISoFi Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $165K 9,742 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 5 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $180K 4,352 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 1 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $106K 2,481 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 57 | Maphai Thabane VincentDirector |  SBSWSibanye Stillwater LtdOpen-market purchase | BUY | $160K 12.0K sh | Mar 19, 2026 traded Mar 16, 2026 |
| 54 | Larson Keith DGeneral Counsel and Secretary |  VGVenture Global, Inc.Open-market sale · 10b5-1 plan | SELL | $26.94M 1.79M sh | Mar 19, 2026 traded Mar 18, 2026 |
| 46 | Zalatoris TimmiChief Human Resources Officer |  SFMSprouts Farmers Market, Inc.Open-market sale | SELL | $784K 9,340 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 46 | Mottiwala AzizChief Commercial Officer |  TARSTarsus Pharmaceuticals, Inc.Open-market sale | SELL | $298K 4,286 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 46 | Blake SarahSVP, Chief Accounting Officer | VGVenture Global, Inc. Open-market sale · 10b5-1 plan | SELL | $3.20M 200.0K sh | Mar 19, 2026 traded Mar 19, 2026 |
| 46 | Azamian Bobak R.Director, President/CEO and Board Chair | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $802K 12.0K sh | Mar 19, 2026 traded Mar 19, 2026 |
| 46 | Wahl BryanGeneral Counsel | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $284K 4,084 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 46 | Azamian Bobak R.Director, President/CEO and Board Chair | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $802K 11.7K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 45 | Larson Keith DGeneral Counsel and Secretary | VGVenture Global, Inc. Open-market sale · 10b5-1 plan | SELL | $49.85M 3.21M sh | Mar 19, 2026 traded Mar 19, 2026 |
| 45 | Little Harrison JamesExecutive Vice President |  KYNKayne Anderson Energy Infrastructure Fund, Inc.Open-market purchase | BUY | $71K 5,000 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 44 | Sfadia AdiCEO |  GILTGILAT SATELLITE NETWORKS LTDOpen-market sale | SELL | $632K 37.5K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 43 | Barker Richard B.EVP and CFO |  NENoble Corp plcOpen-market sale | SELL | $2.22M 47.2K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 43 | Barker Richard B.EVP and CFO | NENoble Corp plc Open-market sale | SELL | $4.77M 102.8K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 42 | Wahl BryanGeneral Counsel | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $283K 4,231 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 42 | Mottiwala AzizChief Commercial Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $298K 4,330 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 42 | Whitfield Dianne C.Chief Human Resources Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $280K 4,174 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 42 | Wahl BryanGeneral Counsel | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $283K 4,125 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 42 | Lam DennisDirector |  HFFGHF Foods Group Inc.Open-market purchase | BUY | $14K 8,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 42 | Tomasso Christopher AnthonyDirector, President and CEO |  FWRGFirst Watch Restaurant Group, Inc.Open-market sale | SELL | $314K 25.1K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 42 | Neervannan SeshadriChief Operating Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $307K 4,589 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 42 | Sinclair JackDirector, Chief Executive Officer | SFMSprouts Farmers Market, Inc. Open-market sale | SELL | $397K 4,754 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 42 | Whitfield Dianne C.Chief Human Resources Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $280K 4,029 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 42 | Whitfield Dianne C.Chief Human Resources Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $280K 4,071 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 42 | Azamian Bobak R.Director, President/CEO and Board Chair | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $762K 11.0K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 42 | Mottiwala AzizChief Commercial Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $297K 4,440 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 41 | Schuyler KevinDirector |  VEEETwin Vee PowerCats, Co.Open-market purchase | BUY | $10K 25.0K sh | Mar 19, 2026 traded Mar 19, 2026 |
| 41 | Sfadia AdiCEO | GILTGILAT SATELLITE NETWORKS LTD Open-market sale | SELL | $126K 7,500 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 40 | Hoitt JasonChief Patient Officer |  STOKStoke Therapeutics, Inc.Open-market sale | SELL | $25K 748 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 40 | Leggett ThomasChief Financial Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $42K 1,274 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 40 | Hoitt JasonChief Patient Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $34K 1,033 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 40 | Leggett ThomasChief Financial Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $31K 922 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 39 | Hoitt JasonChief Patient Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $55K 1,762 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 39 | Neervannan SeshadriChief Operating Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $217K 3,125 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 39 | Eifler Robert W.Director, President & CEO | NENoble Corp plc Open-market sale | SELL | $3.38M 72.8K sh | Mar 19, 2026 traded Mar 18, 2026 |